Journal of the American Medical
[back] Allopathic Inc
[2016 April] 'Oops... It Wasn't Cancer After All,' Admits The National Cancer Institute/JAMA When the NCI report was released, it was a sort of vindication for those who had been advocating the position that a commonly diagnosed form of so-called “early breast cancer” known as ductal carcinoma in situ was in fact not inherently malignant and should not have warranted the conventional treatments of lumpectomy, mastectomy, radiation, and chemotherapy....On April 14th, in an article titled “Its Not Cancer: Doctors Reclassify a Thyroid Tumor,” theNew York Times reported on a new study published in JAMA Oncology which should forever change the way we classify, diagnosis and treat a common form of “thyroid cancer”: An international panel of doctors has decided that a type of tumor that was classified as a cancer is not a cancer at all. As a result, they have officially downgraded the condition, and thousands of patients will be spared removal of their thyroid, treatment with radioactive iodine and regular checkups for the rest of their lives, all to protect against a tumor that was never a threat
Patient Advocacy Group Calls For Suspension Of JAMA Editors,
"We are deeply concerned about the unbecoming and unethical conduct of the Editor-in-chief and Executive Deputy Editor of the Journal of the American Medical Association, who were reported to have used unprofessional and intimidating tactics against a conscientious academic, Dr. Jonathan Leo. Their behavior undermines the integrity of the JAMA peer review process, first, by failing to properly vet a manuscript for the accuracy of scientific reporting and for author conflict of interest and bias and, second, by launching an ad hominem attack on the scientist who was attempting to correct the record...."